How many email patterns does Ultimovacs ASA use?

Ultimovacs ASA uses 1 known email pattern.

What domain does Ultimovacs ASA use for work emails?

Ultimovacs ASA uses ultimovacs.com for work email addresses.

Most Common Email Formats at Ultimovacs ASA

Ultimovacs ASA's most common email format is First.Last@ultimovacs.com (ex. John.Doe@ultimovacs.com), used for 100% of ultimovacs.com addresses. Ultimovacs ASA uses 1 email pattern.

@ultimovacs.com

1 pattern

Format	Example	Share of ultimovacs.com
First.Last@ultimovacs.comMost common	John.Doe@ultimovacs.com	100%

Need a specific person's email?

Browse Ultimovacs ASA's employee directory (about 1 employees) and reveal verified emails free.

Frequently Asked Questions

What does Ultimovacs ASA do?

Ultimovacs ASA was founded in 2011 and operates in the Biotechnology Research industry, alongside similar companies like Roche, Sanofi and Johnson & Johnson. You can visit ultimovacs.com or contact Ultimovacs ASA's headquarters by phone at

+47-450-22****

. Explore Ultimovacs ASA's company overview page for more information.

What is Ultimovacs ASA's email address format?

Ultimovacs ASA's email format typically follows the pattern of First.Last@ultimovacs.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Ultimovacs ASA have currently?

Ultimovacs ASA has approximately 1 employees as of October 2026. Key team members to contact include Cso: G. G., Chief Financial Officer: H. V. and : M. W. For more team information and contact data, explore Ultimovacs ASA's employee directory with LeadIQ.

Ultimovacs ASA Email Format

Biotechnology ResearchOslo, Norway0-1 Employees

Ultimovacs is a biotechnology company focused on developing novel cancer immunotherapies. Its lead candidate UV1 is a peptide-based vaccine designed to elicit a targeted T cell response against telomerase, a broadly expressed cancer antigen. UV1 is being explored as a therapeutic cancer vaccine intended for use in combination with other immuno-oncology drugs, with a broad clinical program spanning Europe, Australia, and the USA.

Founded in 2011, the company traces its research origins to Oslo University Hospital and is headquartered in Oslo, with an additional office in Uppsala, Sweden, and it is publicly listed on Euronext Oslo. In recent developments, there have been reports of strategic activity involving Zelluna Immunotherapy and a planned business combination.

Most common format

First.Last@ultimovacs.com

Example: John.Doe@ultimovacs.com

1 pattern. See all formats

Verify a Ultimovacs ASA email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Ultimovacs ASA

@ultimovacs.com

Need a specific person's email?

Frequently Asked Questions

What does Ultimovacs ASA do?

What is Ultimovacs ASA's email address format?

How many employees does Ultimovacs ASA have currently?

Ultimovacs ASA Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.